当前位置:
X-MOL 学术
›
Breast Cancer Res. Treat.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Luminal subtypes and response to neoadjuvant chemotherapy for hormone receptor-positive HER2-negative patients.
Breast Cancer Research and Treatment ( IF 3.0 ) Pub Date : 2020-09-04 , DOI: 10.1007/s10549-020-05883-0 Kadri Altundag 1
中文翻译:
激素受体阳性HER2阴性患者的发光亚型和对新辅助化疗的反应。
更新日期:2020-09-04
Breast Cancer Research and Treatment ( IF 3.0 ) Pub Date : 2020-09-04 , DOI: 10.1007/s10549-020-05883-0 Kadri Altundag 1
Affiliation
中文翻译:
激素受体阳性HER2阴性患者的发光亚型和对新辅助化疗的反应。